PenDel: Penicillin Allergy Delabeling Among Surgical Patients
Sponsor
University Medicine Greifswald (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05956080
Collaborator
(none)
600
1
24
Study Details
Study Description
Brief Summary
Penicillin allergy testing among surgical patients
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Study Type:
Interventional
Anticipated Enrollment
:
600 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Penicillin Allergy Delabeling Among Surgical Patients
Anticipated Study Start Date
:
Sep 1, 2023
Anticipated Primary Completion Date
:
Sep 1, 2025
Anticipated Study Completion Date
:
Sep 1, 2025
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: Allergy testing
|
Diagnostic Test: Allergy testing
University Medicine Greifswald
|
Outcome Measures
Primary Outcome Measures
- Confirmed penicillin allergy [1 week]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- surgical patients with reported penicillin allergy
Exclusion Criteria:
- missing consent
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Medicine Greifswald
Investigators
- Principal Investigator: Sebastian Gibb, MD, University Medicine Greifswald
- Principal Investigator: Christian S. Scheer, MD, University Medicine Greifswald
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Medicine Greifswald
ClinicalTrials.gov Identifier:
NCT05956080
Other Study ID Numbers:
- 003
First Posted:
Jul 21, 2023
Last Update Posted:
Jul 21, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: